74 research outputs found

    Sq and EEJ—A Review on the Daily Variation of the Geomagnetic Field Caused by Ionospheric Dynamo Currents

    Full text link

    Whole-genome sequencing reveals host factors underlying critical COVID-19

    Get PDF
    Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic variation influences the development of illness requiring critical care1 or hospitalization2,3,4 after infection with SARS-CoV-2. The GenOMICC (Genetics of Mortality in Critical Care) study enables the comparison of genomes from individuals who are critically ill with those of population controls to find underlying disease mechanisms. Here we use whole-genome sequencing in 7,491 critically ill individuals compared with 48,400 controls to discover and replicate 23 independent variants that significantly predispose to critical COVID-19. We identify 16 new independent associations, including variants within genes that are involved in interferon signalling (IL10RB and PLSCR1), leucocyte differentiation (BCL11A) and blood-type antigen secretor status (FUT2). Using transcriptome-wide association and colocalization to infer the effect of gene expression on disease severity, we find evidence that implicates multiple genes—including reduced expression of a membrane flippase (ATP11A), and increased expression of a mucin (MUC1)—in critical disease. Mendelian randomization provides evidence in support of causal roles for myeloid cell adhesion molecules (SELE, ICAM5 and CD209) and the coagulation factor F8, all of which are potentially druggable targets. Our results are broadly consistent with a multi-component model of COVID-19 pathophysiology, in which at least two distinct mechanisms can predispose to life-threatening disease: failure to control viral replication; or an enhanced tendency towards pulmonary inflammation and intravascular coagulation. We show that comparison between cases of critical illness and population controls is highly efficient for the detection of therapeutically relevant mechanisms of disease

    MÖSSBAUER-BORRMANN SUPERRADIANCE

    No full text
    Considérons le comportement cinétique d'un laser pour produire des rayons gamma, construit de noyaux isomériques aux sites de réseau d'un cristal parfait et simple, dont les dimensions et la structure sont choisies pour favoriser l'émission anormale dans le mode de Borrmann qui contient le nombre maximum de reflexions de Bragg. Ceci réduit fortement l'excitation requise pour le lasing. Notre analyse de plusieurs systèmes hypothétiques démontre que la superradiance, plutôt que l'amplification d'émission spontanée, sera le mode d'opération, pour autant que les noyaux isomériques soient pompés très rapidement à un niveau Mossbauer de durée courte et que l'intégrité du cristal soit préservée. Ce résultat justifie la recherche de solution aux problèmes principaux : noyaux candidats, préparation de l'isomère, et transfert du niveau isomérique au niveau lasant.We consider the kinetic behavior of a gamma-ray laser comprising an array of isomeric nuclei located at regular lattice sites in a perfect single crystal of dimensions and structure so chosen as to favor anomalous emission into that Borrmann mode having the maximum possible number of component Bragg-reflected beams, which greatly reduces the excitation requirements. Our analysis of several hypothetical systems shows that superradiance, rather than amplified spontaneous emission, will then be the preferred mode of deexcitation, provided the nuclei can be pumped rapidly to a short-lived Mossbauer level while preserving crystal integrity. This warrants a search for solutions to the major problems : candidate nuclides. preparation of a storage isomer, and interlevel transfer from storage to lasing state

    The role of religion in decision-making on antenatal screening of congenital anomalies: A qualitative study amongst Muslim Turkish origin immigrants

    No full text
    Objective: to explore what role religious beliefs of pregnant Muslim women play in their decision-making on antenatal screening, particularly regarding congenital abnormalities and termination, and whether their interpretations of the religious doctrines correspond to the main sources of Islam. Design: qualitative pilot study using in-depth interviews with pregnant Muslim women. Setting: one midwifery practice in a medium-sized city near Amsterdam participated in the study. Participants: 10 pregnant Muslim women of Turkish origin who live in a high density immigrant area and who attended primary midwives for antenatal care were included in the study. Data collection and data analysis: to explore the role of religion in decision-making on antenatal screening tests, a topic list was constructed, including four subjects: being a (practising) Muslim, the view on unborn life, the view on disabled life and the view on termination. To analyse the interviews, open and axial coding based on the Grounded Theory was used and descriptive and analytical themes were identified and interpreted. Findings: all 10 interviewees stated that their faith played a role in their decision-making on antenatal screening, specific to the combined test. They did not consider congenital anomalies as a problem and did not consider termination to be an option in case of a disabled fetus. However, the Islamic jurisprudence considers that termination is allowed if the fetus has serious abnormalities, but only before 19 weeks plus one day of gestation. Key conclusions: religious convictions play a role regarding antenatal screening in pregnant Muslim women of Turkish origin. The interviewees did not consider a termination in case of an affected child. Women were unaware that within Islamic tradition there is the possibility of termination if a fetus has serious anomalies. Incomplete knowledge of religious doctrines may be influencing both decisions of antenatal screening and diagnostic tests uptake and of terminating a pregnancy for fetuses with serious anomalies. Implications for practise: counsellors should be aware of the role of religious beliefs in the decision-making process on antenatal screening tests. © 2013 The Authors
    corecore